Current Edition

Healthcare Research in United Arab Emirates
Editorial Archive

Healthcare Research in United Arab Emirates

The UAE has rapidly transformed its healthcare sector in the past decade. Adhiti Sharad Kumar explains the UAE’s 2021 Vision, which states that the UAE will invest co...
Continue Reading →
A Decade of Biosimilars: Have Expectations Been Met?
Editorial Archive

A Decade of Biosimilars: Have Expectations Been Met?

Innovator companies have employed a variety of multipronged strategies to counter biosimilar competition. These include development of ‘biobetter’, gaining regulatory...
Continue Reading →
Clinical Trial’s Role in Compliance and Patient Safety
Editorial Archive

Clinical Trial’s Role in Compliance and Patient Safety

Although James Lind conducted the first controlled clinical trial back in 1747, it wasn’t until the Nuremberg Code in 1947 and the Declaration of Helsinki in 1964 tha...
Continue Reading →
How can Modelling and Simulation Fuel the Clinical  Development of Biosimilars?
Editorial Archive

How can Modelling and Simulation Fuel the Clinical Development of Biosimilars?

The relatively low cost to enter the “generic” market and the size of the biologic drug market make entry attractive. However, the failure rate for biosimilars is dee...
Continue Reading →
Health Informatics Data: Connecting Patients to Investigators
Editorial Archive

Health Informatics Data: Connecting Patients to Investigators

From the perspective of a clinical trial, a rare disease suggests the available patient and site population is quite small and distributed diffusely. Likewise, any ch...
Continue Reading →
Everything Old is New Again: Bacteriophage Therapy
Editorial Archive

Everything Old is New Again: Bacteriophage Therapy

Bacteriophages are viruses that can be found inside plants and animals and in soil, rivers, oceans, and even sewers. Phages invade bacterial cells and inject their DN...
Continue Reading →